The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
July 21, 2025
View Complete Issue         Table of Contents 2019 
Avmapki Fakzynja Co-Pack for Ovarian Cancer (online only)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Avmapki Fakzynja Co-Pack for Ovarian Cancer (online only)
July 21, 2025 (Issue: 1733)
Avmapki Fakzynja Co-Pack (Verastem), a combination of the kinase inhibitors avutometinib and defactinib, has received accelerated approval from the FDA for treatment of KRAS-mutated recurrent low-grade serous ovarian cancer in women who had...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Avmapki Fakzynja Co-Pack for Ovarian Cancer (online only)
Article code: 1733j
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.